Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Losartan potassium
Pinewood Laboratories Ltd
C09CA; C09CA01
Losartan potassium
50 milligram(s)
Film-coated tablet
Product subject to prescription which may be renewed (B)
Angiotensin II antagonists, plain; losartan
Marketed
2007-10-12
PACKAGE LEAFLET: INFORMATION FOR THE USER LOSARTAN POTASSIUM PINEWOOD 50 MG LOSARTAN POTASSIUM PINEWOOD 100 MG FILM-COATED TABLETS LOSARTAN POTASSIUM READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Losartan Potassium Pinewood is and what it is used for 2. What you need to know before you take Losartan Potassium Pinewood 3. How to take Losartan Potassium Pinewood 4. Possible side effects 5. How to store Losartan Potassium Pinewood 6. Contents of the pack and other information 1. WHAT LOSARTAN POTASSIUM PINEWOOD IS AND WHAT IT IS USED FOR Losartan belongs to a group of medicines known as angiotensin-II receptor antagonists. Angiotensin-II is a substance produced in the body which binds to receptors in blood vessels, causing them to tighten. This results in an increase in blood pressure. Losartan prevents the binding of angiotensin-II to these receptors, causing the blood vessels to relax which in turn lowers the blood pressure. Losartan slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes. LOSARTAN POTASSIUM PINEWOOD IS USED to treat patients with high blood pressure (hypertension) in adults and in children and adolescents 6 – 18 years of age. to protect the kidney in hypertensive type 2 diabetic patients with laboratory evidence of impaired renal function and proteinuria > 0.5 g per day (a condition in which urine contains an abnormal amount of protein). to treat patients with chronic heart failure when therapy with specific medicine Read the complete document
Health║Products║Regulatory║Authority 28║September║2022 CRN00CVXW Page║1║of║15 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Losartan║Potassium║Pinewood║50║mg║film-coated║tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Losartan║Potassium║Pinewood║contains║50║mg║of║the║active║ingredient║losartan║potassium. Excipient(s)║with║known║effect: Lactose║monohydrate║25.50║mg║and║other║excipients. For║the║full║list║of║excipients,║see║section║6.1.║ 3 PHARMACEUTICAL FORM Film-coated║tablets. Round,║white,║film-coated║tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment║of║essential║hypertension║in║adults║and║in║children║and║adolescents║6║–║18║years║of║age. Treatment║of║renal║disease║in║adult║patients║with║hypertension║and║type║2║diabetes║mellitus║with║proteinuria║>║0.5║ g/day║as║part║of║an║antihypertensive║treatment║(see║sections║4.3,║4.4,║4.5,║and║5.1). Treatment║of║chronic║heart║failure║in║adult║patients,║when║treatment║with║Angiotensin-converting║enzyme║(ACE)║ inhibitors║is║not║considered║suitable║due║to║incompatibility_, especially cough, _or║contraindication.║Patients║with║ heart║failure║who║have║been║stabilised║with║an║ACE║inhibitor║should║not║be║switched║to║losartan.║The║patients║ should║have║a║left║ventricular║ejection║fraction║<║40%║and║should║be║clinically║stable║and║on║an║established║ treatment║regimen║for║chronic║heart║failure. Reduction║in║the║risk║of║stroke║in║adult║hypertensive║patients║with║left║ventricular║hypertrophy║documented║by║ECG║ (see║section║5.1║LIFE║study,║Race). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Hypertension The║usual║starting║and║maintenance║dose║is║50 Read the complete document